Radiotherapy combination opportunities leveraging immunity for the next oncology practice (Q26738443)

adaptive radiation therapy

Europe PubMed Central

title

Radiotherapy combination opportunities leveraging immunity for the next oncology practice (English)

0 references

main subject

0 references

George Coukos

3

0 references

author name string

Fernanda G Herrera

series ordinal

1

0 references

Jean Bourhis

series ordinal

2

0 references

language of work or name

English

0 references

publication date

29 August 2016

0 references

published in

CA

0 references

cites work

Image-guided radiotherapy: from current concept to future perspectives

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Induction of cell death by radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Abscopal regression of hepatocellular carcinoma after radiotherapy for bone metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The controversial abscopal effect

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

In situ vaccination with a TLR9 agonist induces systemic lymphoma regression: a phase I/II study

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Abscopal effects of radiotherapy on advanced melanoma patients who progressed after ipilimumab immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Immunologic correlates of the abscopal effect in a patient with melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

An abscopal response to radiation and ipilimumab in a patient with metastatic non-small cell lung cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

A systemic complete response of metastatic melanoma to local radiation and immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Phase 1 study of stereotactic body radiotherapy and interleukin-2--tumor and immunological responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ionizing radiation inhibition of distant untreated tumors (abscopal effect) is immune mediated

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiation-induced equilibrium is a balance between tumor cell proliferation and T cell-mediated killing

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiotherapy of human sarcoma promotes an intratumoral immune effector signature.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Calreticulin exposure dictates the immunogenicity of cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The co-translocation of ERp57 and calreticulin determines the immunogenicity of cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Calreticulin is the dominant pro-phagocytic signal on multiple human cancers and is counterbalanced by CD47

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Cell-surface calreticulin initiates clearance of viable or apoptotic cells through trans-activation of LRP on the phagocyte

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radioprotection in normal tissue and delayed tumor growth by blockade of CD47 signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

CD91-dependent programming of T-helper cell responses following heat shock protein immunization

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Complement is a central mediator of radiotherapy-induced tumor-specific immunity and clinical response

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

STING-Dependent Cytosolic DNA Sensing Promotes Radiation-Induced Type I Interferon-Dependent Antitumor Immunity in Immunogenic Tumors.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Molecular identification of a danger signal that alerts the immune system to dying cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

gamma-Irradiation induces P2X(7) receptor-dependent ATP release from B16 melanoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

High-mobility group box 1, oxidative stress, and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Pannexin 1 channels mediate 'find-me' signal release and membrane permeability during apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Autophagy-dependent anticancer immune responses induced by chemotherapeutic agents in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Partial volume rat lung irradiation: temporal fluctuations of in-field and out-of-field DNA damage and inflammatory cytokines following irradiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Autophagy inhibition radiosensitizes in vitro, yet reduces radioresponses in vivo due to deficient immunogenic signalling

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Immunogenic death of colon cancer cells treated with oxaliplatin

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The interaction between HMGB1 and TLR4 dictates the outcome of anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Abscopal effect of radiation therapy: Interplay between radiation dose and p53 status

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Antitumor effect of intratumoral administration of bone marrow-derived dendritic cells transduced with wild-type p53 gene.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Maximizing tumor immunity with fractionated radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

p53-dependent chemokine production by senescent tumor cells supports NKG2D-dependent tumor elimination by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Human NK cells are alerted to induction of p53 in cancer cells by upregulation of the NKG2D ligands ULBP1 and ULBP2.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Type, density, and location of immune cells within human colorectal tumors predict clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Immune infiltration in human tumors: a prognostic factor that should not be ignored

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

T-cell responses to survivin in cancer patients undergoing radiation therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Resistance of CD45RA- T cells to apoptosis and functional impairment, and activation of tumor-antigen specific T cells during radiation therapy of prostate cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Standard treatments induce antigen-specific immune responses in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiation-induced CXCL16 release by breast cancer cells attracts effector T cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

External beam radiation of tumors alters phenotype of tumor cells to render them susceptible to vaccine-mediated T-cell killing

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Macrophage regulation of tumor responses to anticancer therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Arginase I production in the tumor microenvironment by mature myeloid cells inhibits T-cell receptor expression and antigen-specific T-cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Polarization of tumor-associated macrophages: a novel strategy for vascular normalization and antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Low-dose irradiation programs macrophage differentiation to an iNOS⁺/M1 phenotype that orchestrates effective T cell immunotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiation enhances regulatory T cell representation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

TGF-β induces the expression of the adaptor Ndfip1 to silence IL-4 production during iTreg cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Regulatory T cells in γ irradiation-induced immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ionizing radiation selectively reduces skin regulatory T cells and alters immune function

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

In situ observation of the effects of local irradiation on cytotoxic and regulatory T lymphocytes in cervical cancer tissue

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Different radiosensitivity of CD4(+)CD25(+) regulatory T cells and effector T cells to low dose gamma irradiation in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The efficacy of radiotherapy relies upon induction of type i interferon-dependent innate and adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiation-induced IFN-gamma production within the tumor microenvironment influences antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8{alpha}+ dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Phase I study of individualized stereotactic body radiotherapy of liver metastases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Sublethal irradiation of human tumor cells modulates phenotype resulting in enhanced killing by cytotoxic T lymphocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Deciphering and reversing tumor immune suppression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Up-regulation of CD40 with juxtacrine activity in human nonsmall lung cancer cells correlates with poor prognosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

CD40 agonists alter tumor stroma and show efficacy against pancreatic carcinoma in mice and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The human agonistic CD40 antibody ADC-1013 eradicates bladder tumors and generates T-cell-dependent tumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Clinical activity and immune modulation in cancer patients treated with CP-870,893, a novel CD40 agonist monoclonal antibody.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Anti-CD40 monoclonal antibody therapy in combination with irradiation results in a CD8 T-cell-dependent immunity to B-cell lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiotherapy increases the permissiveness of established mammary tumors to rejection by immunomodulatory antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Pathogen recognition and innate immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

VTX-2337 is a novel TLR8 agonist that activates NK cells and augments ADCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ligand-induced conformational changes allosterically activate Toll-like receptor 9.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

TLR9 signaling in the tumor microenvironment initiates cancer recurrence after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

An in situ autologous tumor vaccination with combined radiation therapy and TLR9 agonist therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Synergy of topical toll-like receptor 7 agonist with radiation and low-dose cyclophosphamide in a mouse model of cutaneous breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Systemic delivery of a TLR7 agonist in combination with radiation primes durable antitumor immune responses in mouse models of lymphoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Single dose of anti-CTLA-4 enhances CD8+ T-cell memory formation, function, and maintenance

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Fractionated but not single-dose radiotherapy induces an immune-mediated abscopal effect when combined with anti-CTLA-4 antibody

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiation and dual checkpoint blockade activate non-redundant immune mechanisms in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Focal radiation therapy combined with 4-1BB activation and CTLA-4 blockade yields long-term survival and a protective antigen-specific memory response in a murine glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiotherapy-induced anti-tumor immunity contributes to the therapeutic efficacy of irradiation and can be augmented by CTLA-4 blockade in a mouse model

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Suppressing T cell motility induced by anti-CTLA-4 monotherapy improves antitumor effects

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Invariant natural killer T cells regulate anti-tumor immunity by controlling the population of dendritic cells in tumor and draining lymph nodes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Improved Survival with Ipilimumab in Patients with Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

CTLA-4 control over Foxp3+ regulatory T cell function

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ipilimumab-dependent cell-mediated cytotoxicity of regulatory T cells ex vivo by nonclassical monocytes in melanoma patients

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Anti-CTLA-4 antibodies of IgG2a isotype enhance antitumor activity through reduction of intratumoral regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

PD-L2 is a second ligand for PD-1 and inhibits T cell activation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Tumor Immunotherapy Directed at PD-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Safety, activity, and immune correlates of anti-PD-1 antibody in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Survival, durable tumor remission, and long-term safety in patients with advanced melanoma receiving nivolumab

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Pembrolizumab versus Ipilimumab in Advanced Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Nivolumab versus chemotherapy in patients with advanced melanoma who progressed after anti-CTLA-4 treatment (CheckMate 037): a randomised, controlled, open-label, phase 3 trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Irradiation and anti-PD-L1 treatment synergistically promote antitumor immunity in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Stereotactic Radiation Therapy Augments Antigen-Specific PD-1-Mediated Antitumor Immune Responses via Cross-Presentation of Tumor Antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Induction of tumor-specific T cell immunity by anti-DR5 antibody therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Radiotherapy enhances antitumor effect of anti-CD137 therapy in a mouse Glioma model

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Anti-OX40 monoclonal antibody therapy in combination with radiotherapy results in therapeutic antitumor immunity to murine lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

GCN2 kinase in T cells mediates proliferative arrest and anergy induction in response to indoleamine 2,3-dioxygenase.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The indoleamine 2,3-dioxygenase pathway controls complement-dependent enhancement of chemo-radiation therapy against murine glioblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

1-Methyl-tryptophan can interfere with TLR signaling in dendritic cells independently of IDO activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Kynurenine is an endothelium-derived relaxing factor produced during inflammation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Indoleamine 2,3-dioxygenase is a critical resistance mechanism in antitumor T cell immunotherapy targeting CTLA-4.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Tumor-derived TGFbeta-1 induces dendritic cell apoptosis in the sentinel lymph node.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Transforming growth factor-beta and the immune response to malignant disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

CD4+CD25+ regulatory T cells inhibit natural killer cell functions in a transforming growth factor-beta-dependent manner

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Isoform-specific activation of latent transforming growth factor beta (LTGF-beta) by reactive oxygen species.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Cellular sources of transforming growth factor-beta isoforms in early and chronic radiation enteropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

TGFβ1 inhibition increases the radiosensitivity of breast cancer cells in vitro and promotes tumor control by radiation in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Inhibition of TGF-beta with neutralizing antibodies prevents radiation-induced acceleration of metastatic cancer progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ionizing radiation predisposes nonmalignant human mammary epithelial cells to undergo transforming growth factor beta induced epithelial to mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

TGFβ Is a Master Regulator of Radiation Therapy-Induced Antitumor Immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ablative Tumor Radiation Can Change the Tumor Immune Cell Microenvironment to Induce Durable Complete Remissions

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Therapeutic effects of ablative radiation on local tumor require CD8+ T cells: changing strategies for cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

CSF1R signaling blockade stanches tumor-infiltrating myeloid cells and improves the efficacy of radiotherapy in prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Pembrolizumab for the treatment of non-small-cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Prognostic and predictive value of tumor-infiltrating lymphocytes in a phase III randomized adjuvant breast cancer trial in node-positive breast cancer comparing the addition of docetaxel to doxorubicin with doxorubicin-based chemotherapy: BIG 02-98

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Cyclophosphamide resets dendritic cell homeostasis and enhances antitumor immunity through effects that extend beyond regulatory T cell elimination

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

5-Fluorouracil selectively kills tumor-associated myeloid-derived suppressor cells resulting in enhanced T cell-dependent antitumor immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Antitumor effect of paclitaxel is mediated by inhibition of myeloid-derived suppressor cells and chronic inflammation in the spontaneous melanoma model

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The effects of gemcitabine and capecitabine combination chemotherapy and of low-dose adjuvant GM-CSF on the levels of myeloid-derived suppressor cells in patients with advanced pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

The immunologic aspects in advanced ovarian cancer patients treated with paclitaxel and carboplatin chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Vaccination during myeloid cell depletion by cancer chemotherapy fosters robust T cell responses

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Vaccine-induced tumor necrosis factor-producing T cells synergize with cisplatin to promote tumor cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Low-dose radiation enhances therapeutic HPV DNA vaccination in tumor-bearing hosts

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Increased sensitivity of radiated murine cervical cancer tumors to E7 subunit vaccine-driven CTL-mediated killing induces synergistic anti-tumor activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Tecemotide (L-BLP25) versus placebo after chemoradiotherapy for stage III non-small-cell lung cancer (START): a randomised, double-blind, phase 3 trial

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Phase II trial of Belagenpumatucel-L, a TGF-beta2 antisense gene modified allogeneic tumor vaccine in advanced non small cell lung cancer (NSCLC) patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Neoantigens in cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Therapeutic cancer vaccines.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Predicting immunogenic tumour mutations by combining mass spectrometry and exome sequencing.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Cancer immunology. Mutational landscape determines sensitivity to PD-1 blockade in non-small cell lung cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Genetic basis for clinical response to CTLA-4 blockade in melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Persistent antigen at vaccination sites induces tumor-specific CD8⁺ T cell sequestration, dysfunction and deletion

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Mining exomic sequencing data to identify mutated antigens recognized by adoptively transferred tumor-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Soluble plasma HLA peptidome as a potential source for cancer biomarkers

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Combining a recombinant cancer vaccine with standard definitive radiotherapy in patients with localized prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Long-term survival and PSA control with radiation and immunotherapy for node positive prostate cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Safety and immunologic response of a viral vaccine to prostate-specific antigen in combination with radiation therapy when metronomic-dose interleukin 2 is used as an adjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Is the "3+3" dose-escalation phase I clinical trial design suitable for therapeutic cancer vaccine development? A recommendation for alternative design.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

First-line chemoimmunotherapy in metastatic breast carcinoma: combination of paclitaxel and IMP321 (LAG-3Ig) enhances immune responses and antitumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

An HPV-E6/E7 immunotherapy plus PD-1 checkpoint inhibition results in tumor regression and reduction in PD-L1 expression

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Unique potential of 4-1BB agonist antibody to promote durable regression of HPV+ tumors when combined with an E6/E7 peptide vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Modulation of inflammatory immune reactions by low-dose ionizing radiation: molecular mechanisms and clinical application.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Low-dose hypersensitivity: current status and possible mechanisms.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Low-dose fractionated radiotherapy and concomitant chemotherapy in glioblastoma multiforme with poor prognosis: a feasibility study.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Low-dose abdominal radiation as a docetaxel chemosensitizer for recurrent epithelial ovarian cancer: a phase I study of the Gynecologic Oncology Group

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Low-dose fractionated radiation potentiates the effects of cisplatin independent of the hyper-radiation sensitivity in human lung cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Cancer control related to stimulation of immunity by low-dose radiation

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Role of CD28/B7 costimulation and IL-12/IL-10 interaction in the radiation-induced immune changes

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Activation of immunological network by chronic low-dose-rate irradiation in wild-type mouse strains: analysis of immune cell populations and surface molecules

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Suppression of thymic lymphoma induction by life-long low-dose-rate irradiation accompanied by immune activation in C57BL/6 mice

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Increased intensity lymphodepletion enhances tumor treatment efficacy of adoptively transferred tumor-specific T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Adoptive transfer of Mammaglobin-A epitope specific CD8 T cells combined with a single low dose of total body irradiation eradicates breast tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Local delivery of interleukin-12 using T cells targeting VEGF receptor-2 eradicates multiple vascularized tumors in mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Removal of homeostatic cytokine sinks by lymphodepletion enhances the efficacy of adoptively transferred tumor-specific CD8+ T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling.

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Adoptive cell therapy for patients with metastatic melanoma: evaluation of intensive myeloablative chemoradiation preparative regimens

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Randomized, Prospective Evaluation Comparing Intensity of Lymphodepletion Before Adoptive Transfer of Tumor-Infiltrating Lymphocytes for Patients With Metastatic Melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Calreticulin exposure is required for the immunogenicity of γ-irradiation and UVC light-induced apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Abdominal γ-radiation induces an accumulation of function-impaired regulatory T cells in the small intestine

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Intestinal irradiation and fibrosis in a Th1-deficient environment

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

Protection of early cellular damage in 1 Gy-irradiated mice by the elevation of extracellular adenosine

21 January 2018

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Suppressive effect of low dose total body irradiation on lung metastasis: dose dependency and effective period

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Alteration of cytokine profiles in mice exposed to chronic low-dose ionizing radiation

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Low-dose radiotherapy as a chemopotentiator of gemcitabine in tumors of the pancreas or small bowel: a phase I study exploring a new treatment paradigm

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

CpG oligodeoxynucleotides are potent enhancers of radio- and chemoresponses of murine tumors

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Low-dose radiotherapy as a chemo-potentiator of a chemotherapy regimen with pemetrexed for recurrent non-small-cell lung cancer: A prospective phase II study

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

A comparison of etanercept and methotrexate in patients with early rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Regression of non-irradiated metastases after extracranial stereotactic radiotherapy in metastatic renal cell carcinoma

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Radiation hormesis: its expression in the immune system

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Adenosine, an endogenous anti-inflammatory agent

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Inhibition of transforming growth factor-beta-mediated immunosuppression in tumor-draining lymph nodes augments antitumor responses by various immunologic cell types

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Immunogenic tumor cell death induced by chemoradiotherapy in patients with esophageal squamous cell carcinoma

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Response of crypt paneth cells in the small intestine following total-body gamma-irradiation

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Multi-institutional phase I/II trial of stereotactic body radiation therapy for lung metastases

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Whole body irradiation; radiobiology or medicine?

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

An interesting case of possible abscopal effect in malignant melanoma

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Gamma-ray resistance of regulatory CD4+CD25+Foxp3+ T cells in mice

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Repeated Gamma Irradiation Attenuates Collagen-Induced Arthritis via Up-regulation of Regulatory T Cells but not by Damaging Lymphocytes Directly

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

The suppression of metastases and the change in host immune response after low-dose total-body irradiation in tumor-bearing rats

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Radiotherapy promotes tumor-specific effector CD8+ T cells via dendritic cell activation

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

ATP acts as an agonist to promote stimulus-induced secretion of IL-1 beta and IL-18 in human blood

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Irradiation of tumor cells up-regulates Fas and enhances CTL lytic activity and CTL adoptive immunotherapy

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021

Premortem autophagy determines the immunogenicity of chemotherapy-induced cancer cell death

1 reference

https://api.crossref.org/works/10.3322%2FCAAC.21358

7 January 2021